Autolus
Andrew Mercieca had held various finance and accounting roles in the biotech, pharmaceutical, technology, and electronics sectors. Andrew has been a Chief Financial Officer, Director, Sr. Director, and Financial Controller at companies such as Autolus Ltd., Orphazyme A/S, LifeArc, and Astellas Pharma Europe. Andrew's experience includes responsibilities such as group reporting, financial planning, and analysis, financial control, and budgeting. Andrew is a Fellow of the Institute of Chartered Accountants and holds a degree in Accounting and Finance from the University of Portsmouth.
Autolus
4 followers
Autolus utilises advanced cell programming and manufacturing technologies and we have established a development-stage pipeline of products for the treatment of haematological malignancies and solid tumours.